These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23906794)

  • 1. A novel mechanism of XIAP degradation induced by timosaponin AIII in hepatocellular carcinoma.
    Wang N; Feng Y; Zhu M; Siu FM; Ng KM; Che CM
    Biochim Biophys Acta; 2013 Dec; 1833(12):2890-2899. PubMed ID: 23906794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of autophagy enhances timosaponin AIII-induced lung cancer cell apoptosis and anti-tumor effect in vitro and in vivo.
    Liu J; Deng X; Sun X; Dong J; Huang J
    Life Sci; 2020 Sep; 257():118040. PubMed ID: 32622943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timosaponin A‑III induces autophagy of T‑cell acute lymphoblastic leukemia Jurkat cells via inhibition of the PI3K/Akt/mTOR pathway.
    Wang H; Dong R; Fan WW; Zheng XC; Li AM; Wang WD
    Oncol Rep; 2019 May; 41(5):2937-2944. PubMed ID: 30896824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress.
    King FW; Fong S; Griffin C; Shoemaker M; Staub R; Zhang YL; Cohen I; Shtivelman E
    PLoS One; 2009 Sep; 4(9):e7283. PubMed ID: 19789631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timosaponin AIII, a steroidal saponin, exhibits anti-tumor effect on taxol-resistant cells in vitro and in vivo.
    Song XY; Han FY; Chen JJ; Wang W; Zhang Y; Yao GD; Song SJ
    Steroids; 2019 Jun; 146():57-64. PubMed ID: 30951756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timosaponin AIII mediates caspase activation and induces apoptosis through JNK1/2 pathway in human promyelocytic leukemia cells.
    Huang HL; Chiang WL; Hsiao PC; Chien MH; Chen HY; Weng WC; Hsieh MJ; Yang SF
    Tumour Biol; 2015 May; 36(5):3489-97. PubMed ID: 25542232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timosaponin A-III induces autophagy preceding mitochondria-mediated apoptosis in HeLa cancer cells.
    Sy LK; Yan SC; Lok CN; Man RY; Che CM
    Cancer Res; 2008 Dec; 68(24):10229-37. PubMed ID: 19074891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and β-catenin signaling pathways.
    Jung O; Lee J; Lee YJ; Yun JM; Son YJ; Cho JY; Ryou C; Lee SY
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3963-7. PubMed ID: 27422337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Timosaponin AIII-Based Multifunctional Liposomal Delivery System for Synergistic Therapy Against Hepatocellular Carcinoma Cancer.
    Zhang L; Zhang S; Jiang M; Lu L; Ding Y; Ma N; Zhao Y; Xuchen S; Zhang N
    Int J Nanomedicine; 2021; 16():5531-5550. PubMed ID: 34429598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyphyllin I induced-apoptosis is enhanced by inhibition of autophagy in human hepatocellular carcinoma cells.
    Shi YM; Yang L; Geng YD; Zhang C; Kong LY
    Phytomedicine; 2015 Dec; 22(13):1139-49. PubMed ID: 26598912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII.
    Lu L; Ding Y; Zhang Y; Ho RJ; Zhao Y; Zhang T; Guo C
    Int J Nanomedicine; 2018; 13():1927-1944. PubMed ID: 29636610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors.
    Xiao Z; Ko HL; Goh EH; Wang B; Ren EC
    Carcinogenesis; 2013 Jul; 34(7):1458-67. PubMed ID: 23455382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of mitochondria-dependent apoptosis in HepG2 human hepatocellular carcinoma cells by timosaponin A-III.
    Nho KJ; Chun JM; Kim HK
    Environ Toxicol Pharmacol; 2016 Jul; 45():295-301. PubMed ID: 27344126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timosaponin AIII induces apoptosis and autophagy in human melanoma A375-S2 cells.
    Wang Y; Xu L; Lou LL; Song SJ; Yao GD; Ge MY; Hayashi T; Tashiro SI; Onodera S; Ikejima T
    Arch Pharm Res; 2017 Jan; 40(1):69-78. PubMed ID: 27271334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of autophagy of aggregation-prone ubiquitinated proteins by timosaponin A-III.
    Lok CN; Sy LK; Liu F; Che CM
    J Biol Chem; 2011 Sep; 286(36):31684-96. PubMed ID: 21757721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells.
    Wang N; Pan W; Zhu M; Zhang M; Hao X; Liang G; Feng Y
    Br J Pharmacol; 2011 Sep; 164(2b):731-42. PubMed ID: 21418191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells.
    Kwon HY; Kim JH; Kim B; Srivastava SK; Kim SH
    Arch Toxicol; 2018 Jan; 92(1):241-257. PubMed ID: 28676953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timosaponin AIII Disrupts Cell-Extracellular Matrix Interactions through the Inhibition of Endocytic Pathways.
    Terabayashi T; Takezaki D; Hanada K; Matsuoka S; Sasaki T; Akamine T; Katoh A; Ishizaki T
    Biol Pharm Bull; 2024; 47(10):1648-1656. PubMed ID: 39401908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro.
    Chen YL; Yan MY; Chien SY; Kuo SJ; Chen DR; Cheng CY; Su CC
    Mol Med Rep; 2013 May; 7(5):1487-93. PubMed ID: 23525225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.